Sugi Predict

Sugi Predict / Compounds / SCHEMBL487741

SCHEMBL487741

SCHEMBL487741

Nc1ncc(-c2cccc(NS(=O)(=O)CCN3CCOCC3)c2)cc1OCc1c(F)ccc(F)c1Cl

nearest known ligand 0.51

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ MET P08581 9/20 0.51
▸ MAP4K4 O95819 3/20 0.46
▸ ALK Q9UM73 2/20 0.43
▸ JAK2 O60674 1/20 0.40
▸ MAP4K3 Q8IVH8 1/20 0.40
▸ USP2 O75604 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ CYP3A4 P08684 1/20 0.39
▸ CLK4 Q9HAZ1 1/20 0.39
▸ CYP2C19 P33261 1/20 0.37
▸ BRD4 O60885 1/20 0.37
▸ FYN P06241 1/20 0.37
▸ TGFBR1 P36897 1/20 0.37
▸ ACVR1 Q04771 1/20 0.37
▸ CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30452682 1.00 MET (0.51) METMAP4K4ALKJAK2MAP4K3
SCHEMBL30452745 0.93 MET (0.51) METMAP4K4JAK2MAP4K3FYN
SCHEMBL488343 0.93 MET (0.51) METMAP4K4JAK2MAP4K3FYN
SCHEMBL30454528 0.92 MET (0.51) METMAP4K4JAK2MAP4K3FYN
SCHEMBL488056 0.92 MET (0.51) METMAP4K4JAK2MAP4K3FYN
SCHEMBL30453401 0.92 MET (0.53) METMAP4K4ALKJAK2MAP4K3
SCHEMBL487986 0.92 MET (0.53) METMAP4K4ALKJAK2MAP4K3
SCHEMBL488348 0.90 MET (0.48) METMAP4K4JAK2MAP4K3FYN
SCHEMBL30453487 0.90 MET (0.48) METMAP4K4JAK2MAP4K3FYN
SCHEMBL488191 0.88 MET (0.46) METMAP4K4JAK2MAP4K3FYN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4695588-B2 — — 2011-06-08 — — JP claimed
US-8106197-B2 Aminoheteroaryl compounds as protein kinase inhibitors PFIZER INC. (US) 2012-01-31 — — US disclosed
US-8106197-B2 Aminoheteroaryl compounds as protein kinase inhibitors PFIZER INC. (US) 2012-01-31 — — US disclosed
US-8106197-B2 Aminoheteroaryl compounds as protein kinase inhibitors PFIZER INC. (US) 2012-01-31 — — US disclosed
US-7230098-B2 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer SUGEN, INC. (US) 2007-06-12 — — US disclosed
US-7230098-B2 2-amino- pyridines and pyrazines additionally substituted witn one or more carbocyclic or heterocyclic groups, e.g., 4-[6-amino-5-(2,6-dichloro-benzyloxy)-pyridin-3-yl]-phenol, for treating many kinds of cancer SUGEN, INC. (US) 2007-06-12 — — US disclosed
US-20070072874-A1 Aminoheteroaryl compounds as protein kinase inhibitors SUGEN, INC. 2007-03-29 — — US disclosed
US-20070072874-A1 Aminoheteroaryl compounds as protein kinase inhibitors SUGEN, INC. 2007-03-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070072874-A1 Aminoheteroaryl compounds as protein kinase inhibitors MET, MAP4K1, MAP4K2 MET 1/4885MAP4K4 10/4885ALK 138/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.